Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest W Kovacs

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|March 25, 2004
Interior surface modification of bacteriophage MS2Jacob M Hooker, Ernest W Kovacs, Matthew B Francis
Journal of the American Chemical Society|March 18, 2005
Dual-surface modification of the tobacco mosaic virusTara L Schlick, Zhebo Ding, Ernest W Kovacs, et al.
Bioconjugate Chemistry|July 3, 2007
Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery systemErnest W Kovacs, Jacob M Hooker, Dante W Romanini, et al.
Journal of Virology|September 16, 2024
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugateSeth H Pincus, Frances M Cole, Kelli Ober, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|March 25, 2004
Interior surface modification of bacteriophage MS2Jacob M Hooker, Ernest W Kovacs, Matthew B Francis
Journal of the American Chemical Society|March 18, 2005
Dual-surface modification of the tobacco mosaic virusTara L Schlick, Zhebo Ding, Ernest W Kovacs, et al.
Bioconjugate Chemistry|July 3, 2007
Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery systemErnest W Kovacs, Jacob M Hooker, Dante W Romanini, et al.
Journal of Virology|September 16, 2024
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugateSeth H Pincus, Frances M Cole, Kelli Ober, et al.
Pageof 1